Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02194010
Other study ID # INC 6610
Secondary ID U54NS065712
Status Completed
Phase
First received
Last updated
Start date April 2014
Est. completion date February 2019

Study information

Verified date February 2019
Source University of Iowa
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this research study is to create and validate two patient reported outcome (PRO) questionnaires. PRO questionnaires ask questions that help to measure disability in patients with inherited neuropathies. These questionnaires ask questions about what participants think disability is for themselves or others with inherited neuropathies. These questionnaires are a useful tool when evaluating whether treatments are working in the day to day life of an individual, although there are currently no questionnaires available specifically for people who have Charcot Marie Tooth disease (CMT).


Description:

Charcot Marie Tooth Disease (CMT) is a group of disorders that cause a peripheral neuropathy, impairing the long nerves that go to the feet and hands. Due to the problems with the peripheral nerves, people with CMT have muscle weakness and sensory loss that impairs their physical abilities. CMT affects approximately 1 in 2500 people and is caused my mutations in over 70 different genes. Models exist for many sub-types of CMT that have led to an increased understanding of the biological basis for these disorders. These advances have also made rational therapies for CMT a realistic possibility. However, clinical trials have been limited in CMT by a combination of lack of natural history data for many subtypes, a lack of outcome measures that can detect change in a short period for slowly progressive forms of CMT, and a lack of outcome measures for young children with CMT.

In order to develop treatments based on the biological advances in the inherited neuropathies, it is necessary to have measured the natural history of the various disorders. It is only by knowing the natural history that one understands the onset of clinical symptoms, the rate of progression, and the ultimate prognosis of these diseases. For these reasons, the INC has dedicated much of its effort to develop sensitive outcome instruments, including PRO tools, to measure the natural history of CMT. It is the investigators goal to establish such an instrument for overall impairment for use in both natural history analysis and clinical trials. To develop and validate this instrument, the investigators will be asking people who have CMT to complete two questionnaires, the DSI and the HMSN-R-ODS. These relate to overall symptom impairment due to CMT. These instruments may be used to help us understand the overall progression of CMT and will ultimately help with clinical trials when they are available for the various forms of CMT.


Recruitment information / eligibility

Status Completed
Enrollment 563
Est. completion date February 2019
Est. primary completion date February 2019
Accepts healthy volunteers No
Gender All
Age group 10 Years and older
Eligibility Inclusion Criteria:

- individual has an inherited peripheral neuropathy or is suspected to have an inherited peripheral neuropathy

- individual is 10-99 years of age

- individual signs consent or assent form depending on age and requirements

- individual is participating in INC 6601 at one of the participating sites OR is a participant on the INC Patient Registry

Exclusion Criteria:

- inability to provide informed consent

- outside of age range

- inability to complete questionnaire

- does not understand English

- is not participating in INC 6601 or on the INC Patient Registry

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United Kingdom National Hospital of Neurology and Neurosurgery London
United States University of Iowa Iowa City Iowa
United States University of Rochester Medical Center Rochester New York

Sponsors (6)

Lead Sponsor Collaborator
University of Iowa Charcot-Marie-Tooth Association, Muscular Dystrophy Association, National Institute of Neurological Disorders and Stroke (NINDS), University of Rochester, University of South Florida

Countries where clinical trial is conducted

United States,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Disability Severity Index The DSI asks the subject to provide information about how disability is reflected in general by equipment required for mobility. Therefore, the DSI asks the subject if a person in general was wearing AFOs (braces) for mobility, what level of disability would that reflect using both a quantitative measurement of score and a verbal method of scoring (none, mild, moderate, severe). These questions do not apply to the participant themselves, just in general how disabled they believe a person to be based on the mobility assistive devices that that person requires. Then a research team member will complete the last page which specifically asks about what that subject is using for mobility. Approximately 30 minutes
Secondary Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS) The HMSN-R-ODS is a functional score about the subject asking about their daily activities and overall health. Questions are grouped in various sections and include: Changing and holding body positions; walking and movement; movement by transport; carrying, moving, or handling objects; self-care; household activities and duties; taking care (daily tasks) - general; meeting other people; work, study, and hobbies. These questions relate specifically to the subject and ask how they can perform these various activities with little to severe difficulty. Approximately 30 minutes
See also
  Status Clinical Trial Phase
Completed NCT02561702 - Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease Phase 2
Completed NCT00541164 - Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease Phase 1/Phase 2
Recruiting NCT01918826 - Evaluation of the Analgesic Efficiency of the Transcutaneous Neurostimulation in the Charcot Syndrome Marie Tooth on the Pains of Lower Limbs N/A
Completed NCT01455623 - Development and Validation of a Disability Severity Index for CMT N/A
Recruiting NCT01203085 - Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT
Recruiting NCT01193075 - Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others